BiondVax Pharmaceuticals Ltd.
BVXVW
BVXVW was delisted on the 13th of May, 2020.
0 hedge funds and large institutions have $0 invested in BiondVax Pharmaceuticals Ltd. in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $8K → $0 (-$8K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5K |
| 2 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$5K | -12,590 | Closed |
|
|
FWM
2
Focused Wealth Management
Newburgh,
New York
| – | -$3K | -8,107 | Closed |
|
BVXVW Hedge Fund Activity: Q2 2020 in Review
0 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in BiondVax Pharmaceuticals Ltd. (BVXVW) for Q2 2020, worth a combined $0 — down 100% from $8K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BVXVW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $5K sold.
- 0 institutional investors held BiondVax Pharmaceuticals Ltd. (BVXVW) as of Q2 2020, down from 2 in Q1 2020.
- Funds reported $0 of BiondVax Pharmaceuticals Ltd. stock for Q2 2020, down 100% quarter-over-quarter.
- 0 funds opened new BiondVax Pharmaceuticals Ltd. positions in Q2 2020 and 2 closed out, a net change of -2 holders.
- The largest BiondVax Pharmaceuticals Ltd. seller in Q2 2020 was Susquehanna International Group, an estimated $5K sold.
Based on aggregated 13F filings for Q2 2020.